Send me a link:

*Text messaging rates may apply.

 Dow Down 1.88% Nasdaq Down 2.09%

Alkermes plc (ALKS)

-NasdaqGS
42.76 Down 3.56(7.69%) 3:59PM EDT
|After Hours : 42.76 0.00 (0.00%) 5:12PM EDT
Prev Close:46.32
Open:43.02
Bid:42.40 x 100
Ask:43.10 x 1000
1y Target Est:50.92
Beta:1.5
Next Earnings Date:31-Jul-14ALKS Earnings announcement
Day's Range:42.30 - 44.70
52wk Range:29.36 - 54.25
Volume:2,298,051
Avg Vol (3m):728,173
Market Cap:6.18B
P/E (ttm):N/A
EPS (ttm):-0.03
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALKS

Comparison

Symbol% ChgMkt Cap
ALKSDown 7.69%6.18B
ABTDown 1.73%63.26B
LLYDown 2.49%65.44B
GSKDown 0.21%116.18B

Key Statistics

Forward P/E (1 yr):61.97
P/S (ttm):12.30
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.49
Quarterly EPS Est (Jun-14) :0.14
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):7.22

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alkermes Public Limited Company, an integrated biopharmaceutical company, develops medicines that enhance patient outcomes. The company offers RISPERDAL CONSTA for schizophrenia and bipolar I disorder; INVEGA SUSTENNA to treat schizophrenia; AMPYR... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback